GRANTS

192 RESULTS

You searched adrd-risk-and-disease-following-nervous-system-exposures-biological-interfaces-environment

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in MCI and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required) (RFA-NS-25-010)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: Direct Costs cannot exceed $6,700,000 per year. The maximum project period is 7 years. NIH intends to fund one award contingent upon NIH appropriations.

Due Date: LOI due December 24, 2024. Application due January 24, 2025.

Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed) (PAR-24-121)

Sponsor: National Institute on Aging

Award: NIA intends to fund an estimate of 3-5 awards, corresponding to a total of $2.7 million, each year for fiscal years 2025, 2026, and 2027. Application budgets are not limited, but need to reflect the actual needs of the proposed project.

Due Date: Multiple due dates; see announcement.

Current Filters

  • Keyword: adrd-risk-and-disease-following-nervous-system-exposures-biological-interfaces-environment x

Remove all filters

Filter By